chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram abnormal, Electrocardiogram ambulatory, Fatigue, Heart rate irregular
Clinical narrative: Pronounced awareness of heartbeat; irregular heartbeat; significant increase in tiredness; shortness of breath during minor tasks; periodic dull pain in chest; loss of ability to perform cardio exercise; This is a spontaneous report from a contactable consumer. This 63-year-old male consumer (Patient) reported that:  A 63-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (At the age of 63 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (At the age of 63 years) as DOSE 1, SINGLE for covid-19 immunisation. No known allergies. Medical history included myocardial ischemia from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Atorvastatin (40 mg) and Tamsulosin (.4 mg) taken for an unspecified indication, start and stop date were not reported. On 03Apr2021, the patient had experienced Pronounced awareness of heartbeat, irregular heartbeat, significant increase in tiredness, shortness of breath during minor tasks, periodic dull pain in chest, loss of ability to perform cardio exercise. Symptoms started about 1 week after second dose and have increased since then.The patient underwent lab tests and procedures which included heart rate: irregular on 03Apr2021. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Dyspnoea, Exercise tolerance decreased, Fatigue, Heart rate abnormal
Clinical narrative: Pronounced awareness of heartbeat; irregular heartbeat; significant increase in tiredness; shortness of breath during minor tasks; periodic dull pain in chest; loss of ability to perform cardio exercise; This is a spontaneous report from a contactable consumer. This 63-year-old male consumer (Patient) reported that:  A 63-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (At the age of 63 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (At the age of 63 years) as DOSE 1, SINGLE for covid-19 immunisation. No known allergies. Medical history included myocardial ischemia from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Atorvastatin (40 mg) and Tamsulosin (.4 mg) taken for an unspecified indication, start and stop date were not reported. On 03Apr2021, the patient had experienced Pronounced awareness of heartbeat, irregular heartbeat, significant increase in tiredness, shortness of breath during minor tasks, periodic dull pain in chest, loss of ability to perform cardio exercise. Symptoms started about 1 week after second dose and have increased since then.The patient underwent lab tests and procedures which included heart rate: irregular on 03Apr2021. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Heart rate irregular
Clinical narrative: Pronounced awareness of heartbeat; irregular heartbeat; significant increase in tiredness; shortness of breath during minor tasks; periodic dull pain in chest; loss of ability to perform cardio exercise; This is a spontaneous report from a contactable consumer. This 63-year-old male consumer (Patient) reported that:  A 63-years-old male patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: ER8727), via an unspecified route of administration, administered in Arm Left on 27Mar2021 (At the age of 63 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6205), via an unspecified route of administration, administered in Arm Left on 06Mar2021 (At the age of 63 years) as DOSE 1, SINGLE for covid-19 immunisation. No known allergies. Medical history included myocardial ischemia from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Atorvastatin (40 mg) and Tamsulosin (.4 mg) taken for an unspecified indication, start and stop date were not reported. On 03Apr2021, the patient had experienced Pronounced awareness of heartbeat, irregular heartbeat, significant increase in tiredness, shortness of breath during minor tasks, periodic dull pain in chest, loss of ability to perform cardio exercise. Symptoms started about 1 week after second dose and have increased since then.The patient underwent lab tests and procedures which included heart rate: irregular on 03Apr2021. No treatment was received in response to the adverse events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. At the time of reporting, the outcome of the events were not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest pain, Computerised tomogram thorax, Dizziness, Dyspnoea, Headache
Clinical narrative: Chest pain, extreme dizziness, brain inflammation
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Pulmonary embolism, Tachycardia
Clinical narrative: Chest pain, extreme dizziness, brain inflammation
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest pain, Computerised tomogram, Dizziness, Electrocardiogram
Clinical narrative: Chest pain, extreme dizziness, brain inflammation
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging, Noninfective encephalitis
Clinical narrative: Chest pain, extreme dizziness, brain inflammation
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Loss of personal independence in daily activities, Neuralgia
Clinical narrative: Dirraiah; Vomiting; Body aches, sharp pains; Chest pain; Shortness of breath; Ear pain; Running nose; Brain fog; Headaches; Shaking; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 01May2021 at 14:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01May2021 at 16:00, the patient experienced "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills still going on after 8 days (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Chills, Diarrhoea, Dyspnoea, Ear pain
Clinical narrative: Dirraiah; Vomiting; Body aches, sharp pains; Chest pain; Shortness of breath; Ear pain; Running nose; Brain fog; Headaches; Shaking; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 01May2021 at 14:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01May2021 at 16:00, the patient experienced "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills still going on after 8 days (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Headache, Pain, Rhinorrhoea, Tremor
Clinical narrative: Dirraiah; Vomiting; Body aches, sharp pains; Chest pain; Shortness of breath; Ear pain; Running nose; Brain fog; Headaches; Shaking; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 01May2021 at 14:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01May2021 at 16:00, the patient experienced "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills still going on after 8 days (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: Dirraiah; Vomiting; Body aches, sharp pains; Chest pain; Shortness of breath; Ear pain; Running nose; Brain fog; Headaches; Shaking; Chills; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 01May2021 at 14:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications; taken for unknown indications from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation. On 01May2021 at 16:00, the patient experienced "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills still going on after 8 days (at the time of this report). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events "dirraiah", vomiting, body aches, sharp pains, chest pain, shortness of breath, ear pain, running nose, brain fog, headaches, shaking and chills was not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: After 2 days Tingling throughout body.; After 2 days tingling and burning sensation throughout body; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included pituitary tumour, penicillin allergy. The patient previously received ciprofloxacin (CIPRO) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cabergoline (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown start date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 12:15, the patient experienced tingling and burning sensation throughout body after 2 days of vaccination. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and burning sensation throughout body was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Paraesthesia
Clinical narrative: After 2 days Tingling throughout body.; After 2 days tingling and burning sensation throughout body; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included pituitary tumour, penicillin allergy. The patient previously received ciprofloxacin (CIPRO) for an unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cabergoline (MANUFACTURER UNKNOWN) for an unknown indication, from an unknown start date and unknown if on going. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 12Apr2021 at 12:15, the patient experienced tingling and burning sensation throughout body after 2 days of vaccination. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tingling and burning sensation throughout body was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blister, Lip swelling
Clinical narrative: her lips swelled and blistered; her lips swelled and blistered; This is a spontaneous report from a contactable consumer (Patient's mother) via medical information team. A 20-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection), on 26Apr2021 (Lot number: EW0170, Expiry date: Aug2021) as dose 1, single administered in left arm and on 05Jun2021 (Lot number: EW0187, Expiry date: unknown) as dose 2, single administered in right arm both via intramuscular route of administration (at the age of 20-year-old) for COVID- 19 Immunization. Medical history included Uveitis from Unspecified date and unknown if ongoing. Concomitant medication included steroid via ophthalmic route of administration (drop in her eye) from an unspecified date for an unknown indication and unknown if ongoing. She put one drop per day. Reporter stated her daughter had the first shot of the Pfizer-BioNTech COVID-19 Vaccine and on an unspecified date in Apr2021 her lips swelled and blistered and was taking hydrocortisone. Then she had to get the 2nd shot, her lips continued to be swollen and blistered. Patient had been applying hydrocortisone cream since 07Apr2021 to her lips, now its Jul2021.Reporter stated If she was not putting the cream on her lips, it swell up and get blistered. Reaction that it has not stopped either and this reaction is not going away. Reporter also stated that as read on the internet, other people have this reaction. And queried that how long was it lasting and what do we do about it. When she could stop taking the cream. She was calling because she doesn't want to have her daughter have the booster dose. Reporter queried that Has Pfizer provided a statement on the need for a booster dose (3rd dose). Was Pfizer investigating the need for a booster dose. Report was not serious. Patient visited physician office visit as a result of the events. Therapeutic measures were taken as a result of the events which included Hydrocortisone steroid cream. Outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lip blister, Lip swelling
Clinical narrative: her lips swelled and blistered; her lips swelled and blistered; This is a spontaneous report from a contactable consumer (Patient's mother) via medical information team. A 20-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection), on 26Apr2021 (Lot number: EW0170, Expiry date: Aug2021) as dose 1, single administered in left arm and on 05Jun2021 (Lot number: EW0187, Expiry date: unknown) as dose 2, single administered in right arm both via intramuscular route of administration (at the age of 20-year-old) for COVID- 19 Immunization. Medical history included Uveitis from Unspecified date and unknown if ongoing. Concomitant medication included steroid via ophthalmic route of administration (drop in her eye) from an unspecified date for an unknown indication and unknown if ongoing. She put one drop per day. Reporter stated her daughter had the first shot of the Pfizer-BioNTech COVID-19 Vaccine and on an unspecified date in Apr2021 her lips swelled and blistered and was taking hydrocortisone. Then she had to get the 2nd shot, her lips continued to be swollen and blistered. Patient had been applying hydrocortisone cream since 07Apr2021 to her lips, now its Jul2021.Reporter stated If she was not putting the cream on her lips, it swell up and get blistered. Reaction that it has not stopped either and this reaction is not going away. Reporter also stated that as read on the internet, other people have this reaction. And queried that how long was it lasting and what do we do about it. When she could stop taking the cream. She was calling because she doesn't want to have her daughter have the booster dose. Reporter queried that Has Pfizer provided a statement on the need for a booster dose (3rd dose). Was Pfizer investigating the need for a booster dose. Report was not serious. Patient visited physician office visit as a result of the events. Therapeutic measures were taken as a result of the events which included Hydrocortisone steroid cream. Outcome of the event was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Vaccination site mass
Clinical narrative: Tender lump, mass under left arm; Tender lump, mass under left arm; Sore, under the arm; This is a spontaneous report from a contactable female consumer. This female patient (reported for herself):  A 59-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EW1061, Expiration date- unspecified date of Jul2021), via unspecified route of administration, in left arm on 20Apr2021 10:30 as dose 2, 0.3 ml, single (at the age of 59-years-old) for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734), via unspecified route of administration, in left arm on 30Mar2021 10:30 as a dose 1, 0.3 ml, single for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient not had any adverse events prior to vaccination. On 21Apr2021 the patient experienced sore, under the arm. On 22Apr2021 the patient experienced tender lump, mass under left arm. Patient reported that whenever she tried to reach for something her arm muscle was sore. Patient stated that she read that it was normal for 24 to 48 hours to have soreness. Patient also reported that while showering, she had a tender lump, mass under her left arm. Patient queried if that one was the side effects, of the vaccine. Patient also stated that she does take medications but does not feel they are relevant to the report. Patient not had emergency room and physician office visit for the reported events. The outcome for sore, under the arm was recovered on 21Apr2021. The outcome for tender lump, mass under left arm was unknown.  No follow-up attempts are needed. No further information is expected
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Limb discomfort, Mass excision, Pain in extremity
Clinical narrative: Tender lump, mass under left arm; Tender lump, mass under left arm; Sore, under the arm; This is a spontaneous report from a contactable female consumer. This female patient (reported for herself):  A 59-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EW1061, Expiration date- unspecified date of Jul2021), via unspecified route of administration, in left arm on 20Apr2021 10:30 as dose 2, 0.3 ml, single (at the age of 59-years-old) for COVID-19 immunization. The patient medical history and concomitant medication were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8734), via unspecified route of administration, in left arm on 30Mar2021 10:30 as a dose 1, 0.3 ml, single for COVID-19 immunization. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient not had any adverse events prior to vaccination. On 21Apr2021 the patient experienced sore, under the arm. On 22Apr2021 the patient experienced tender lump, mass under left arm. Patient reported that whenever she tried to reach for something her arm muscle was sore. Patient stated that she read that it was normal for 24 to 48 hours to have soreness. Patient also reported that while showering, she had a tender lump, mass under her left arm. Patient queried if that one was the side effects, of the vaccine. Patient also stated that she does take medications but does not feel they are relevant to the report. Patient not had emergency room and physician office visit for the reported events. The outcome for sore, under the arm was recovered on 21Apr2021. The outcome for tender lump, mass under left arm was unknown.  No follow-up attempts are needed. No further information is expected
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Burning sensation, Eyelid irritation, Eyelids pruritus, Heavy menstrual bleeding, Menstrual disorder
Clinical narrative: I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I felt only a little bit pain in my arm; This is a spontaneous report from a contactable consumer (Patient).   A 35-years-old female patient received bnt162b2 (Pfizer Covid-19 Vaccine, Formulation : Solution for injection, Batch/Lot Number: EW0180), via an unspecified route of administration on 05Jul2021(at the age of 35 years old) for COVID-19 immunization. The patient medical history include high Blood Pressure and diabetes mellitus from an unknown date and unknown if ongoing. The patient received an unspecified concomitant mediation therapy. On 06Jul2021, the patient was feeling fine when she took the shot she sat there for 15-20 minutes and she felt fine and she got up and didn't feel any chills or anything like that she felt only a little bit pain in her arm but that was okay it went away and this morning she got up and she went to use the restroom and when wiped, she noticed there was a lot of blood like she got her period and she was 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere. Treatment not received for the events. Outcome of the event, she got her period 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere was unknown while for she felt only a little bit pain in her arm was recovered on an unspecified date in 2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Pruritus
Clinical narrative: I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I felt only a little bit pain in my arm; This is a spontaneous report from a contactable consumer (Patient).   A 35-years-old female patient received bnt162b2 (Pfizer Covid-19 Vaccine, Formulation : Solution for injection, Batch/Lot Number: EW0180), via an unspecified route of administration on 05Jul2021(at the age of 35 years old) for COVID-19 immunization. The patient medical history include high Blood Pressure and diabetes mellitus from an unknown date and unknown if ongoing. The patient received an unspecified concomitant mediation therapy. On 06Jul2021, the patient was feeling fine when she took the shot she sat there for 15-20 minutes and she felt fine and she got up and didn't feel any chills or anything like that she felt only a little bit pain in her arm but that was okay it went away and this morning she got up and she went to use the restroom and when wiped, she noticed there was a lot of blood like she got her period and she was 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere. Treatment not received for the events. Outcome of the event, she got her period 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere was unknown while for she felt only a little bit pain in her arm was recovered on an unspecified date in 2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Menstruation irregular, Pain in extremity, Vaginal haemorrhage
Clinical narrative: I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I got my period and I am 2 weeks early from getting my period and I know my body it's like, I usually get the symptoms of a period and all this here is heavy blood came out of nowhere; I felt only a little bit pain in my arm; This is a spontaneous report from a contactable consumer (Patient).   A 35-years-old female patient received bnt162b2 (Pfizer Covid-19 Vaccine, Formulation : Solution for injection, Batch/Lot Number: EW0180), via an unspecified route of administration on 05Jul2021(at the age of 35 years old) for COVID-19 immunization. The patient medical history include high Blood Pressure and diabetes mellitus from an unknown date and unknown if ongoing. The patient received an unspecified concomitant mediation therapy. On 06Jul2021, the patient was feeling fine when she took the shot she sat there for 15-20 minutes and she felt fine and she got up and didn't feel any chills or anything like that she felt only a little bit pain in her arm but that was okay it went away and this morning she got up and she went to use the restroom and when wiped, she noticed there was a lot of blood like she got her period and she was 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere. Treatment not received for the events. Outcome of the event, she got her period 2 weeks early from getting her period and she know her body it's like, she usually get the symptoms of a period and all this here is heavy blood came out of nowhere was unknown while for she felt only a little bit pain in her arm was recovered on an unspecified date in 2021.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abortion spontaneous, Blood thyroid stimulating hormone normal, Fatigue, Feeling cold, Hypothyroidism
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to Quinalones. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. On 31Jan2021 at 15:00 the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with allergy medication, night guard and chiropractic. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. The patient had received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 17Feb2021 at 13:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Joint stiffness, Musculoskeletal stiffness, Onychoclasis, Tinnitus, Trichorrhexis
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to Quinalones. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. On 31Jan2021 at 15:00 the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with allergy medication, night guard and chiropractic. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. The patient had received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 17Feb2021 at 13:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Weight increased, Weight loss poor
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to Quinalones. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. On 31Jan2021 at 15:00 the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with allergy medication, night guard and chiropractic. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. The patient had received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 17Feb2021 at 13:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9261) via an unspecified route of administration in the left arm on 29Jan2021 at 13:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to Quinalones. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included loratadine (MANUFACTURER UNKNOWN), multivitamin (MANUFACTURER UNKNOWN) and probiotics (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. On 31Jan2021 at 15:00 the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of event and included treatment with allergy medication, night guard and chiropractic. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report. The patient had received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9810) via an unspecified route of administration in the left arm on 17Feb2021 at 13:00 (at the age of 34-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Brain natriuretic peptide normal, Chest pain, Electrocardiogram ST segment elevation, Electrocardiogram repolarisation abnormality, Pericarditis
Clinical narrative: He received the first of his COVID-19 vaccinations on 9/15/21. Patient felt well Thursday but developed left shoulder pain, fevers, and chills on Friday (09/17) and was seen in the emergency room on 9/18. At that time, chest pain was described as, "sharp, hurts with position changes (hard to get comfortable), and he has occasional shortness of breath with the pain (though no sustained respiratory distress)." Patient found to have an elevated troponin of 0.98 and CRP of 1.6 at that time. An echocardiogram was performed demonstrating a structurally normal heart with good biventricular function.  Discharged home on scheduled Q6h ibuprofen with follow up in cardiology clinic on Monday 09/20. Patient had resolution of chest pain in the interim but, on Monday recheck, his troponin was noted to be elevated at 9 and there were new repolarization changes on his ECG.  A repeat echocardiogram again demonstrated good biventricular function with no pericardial effusion.  When his troponin value was found to be elevated, hospital admission was arranged for evaluation of myo-pericarditis.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: He received the first of his COVID-19 vaccinations on 9/15/21. Patient felt well Thursday but developed left shoulder pain, fevers, and chills on Friday (09/17) and was seen in the emergency room on 9/18. At that time, chest pain was described as, "sharp, hurts with position changes (hard to get comfortable), and he has occasional shortness of breath with the pain (though no sustained respiratory distress)." Patient found to have an elevated troponin of 0.98 and CRP of 1.6 at that time. An echocardiogram was performed demonstrating a structurally normal heart with good biventricular function.  Discharged home on scheduled Q6h ibuprofen with follow up in cardiology clinic on Monday 09/20. Patient had resolution of chest pain in the interim but, on Monday recheck, his troponin was noted to be elevated at 9 and there were new repolarization changes on his ECG.  A repeat echocardiogram again demonstrated good biventricular function with no pericardial effusion.  When his troponin value was found to be elevated, hospital admission was arranged for evaluation of myo-pericarditis.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, C-reactive protein increased, Chest pain, Chills, Discomfort
Clinical narrative: He received the first of his COVID-19 vaccinations on 9/15/21. Patient felt well Thursday but developed left shoulder pain, fevers, and chills on Friday (09/17) and was seen in the emergency room on 9/18. At that time, chest pain was described as, "sharp, hurts with position changes (hard to get comfortable), and he has occasional shortness of breath with the pain (though no sustained respiratory distress)." Patient found to have an elevated troponin of 0.98 and CRP of 1.6 at that time. An echocardiogram was performed demonstrating a structurally normal heart with good biventricular function.  Discharged home on scheduled Q6h ibuprofen with follow up in cardiology clinic on Monday 09/20. Patient had resolution of chest pain in the interim but, on Monday recheck, his troponin was noted to be elevated at 9 and there were new repolarization changes on his ECG.  A repeat echocardiogram again demonstrated good biventricular function with no pericardial effusion.  When his troponin value was found to be elevated, hospital admission was arranged for evaluation of myo-pericarditis.
Age: 13.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram repolarisation abnormality, Pain, Pyrexia, Troponin increased
Clinical narrative: He received the first of his COVID-19 vaccinations on 9/15/21. Patient felt well Thursday but developed left shoulder pain, fevers, and chills on Friday (09/17) and was seen in the emergency room on 9/18. At that time, chest pain was described as, "sharp, hurts with position changes (hard to get comfortable), and he has occasional shortness of breath with the pain (though no sustained respiratory distress)." Patient found to have an elevated troponin of 0.98 and CRP of 1.6 at that time. An echocardiogram was performed demonstrating a structurally normal heart with good biventricular function.  Discharged home on scheduled Q6h ibuprofen with follow up in cardiology clinic on Monday 09/20. Patient had resolution of chest pain in the interim but, on Monday recheck, his troponin was noted to be elevated at 9 and there were new repolarization changes on his ECG.  A repeat echocardiogram again demonstrated good biventricular function with no pericardial effusion.  When his troponin value was found to be elevated, hospital admission was arranged for evaluation of myo-pericarditis.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: The day after vaccination the patient had onset of dense fatigue.  This symptom has been accompanied by headaches, hoarseness, increased neuropathic pain, orthostatic dizziness.  These symptoms have now persisted for one month without significant improvement.  He had similar symptoms after Pfizer COVID vaccine #2 which persisted for about 4 weeks prior to starting to improve but which lasted for about 3 months total. He brought this to my attention at office visit on 10/27 as his symptoms had not begun to improve.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatinine increased, Blood thyroid stimulating hormone, Blood urea increased, C-reactive protein, Dizziness postural
Clinical narrative: The day after vaccination the patient had onset of dense fatigue.  This symptom has been accompanied by headaches, hoarseness, increased neuropathic pain, orthostatic dizziness.  These symptoms have now persisted for one month without significant improvement.  He had similar symptoms after Pfizer COVID vaccine #2 which persisted for about 4 weeks prior to starting to improve but which lasted for about 3 months total. He brought this to my attention at office visit on 10/27 as his symptoms had not begun to improve.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysphonia, Extra dose administered, Fatigue, Full blood count normal, Headache
Clinical narrative: The day after vaccination the patient had onset of dense fatigue.  This symptom has been accompanied by headaches, hoarseness, increased neuropathic pain, orthostatic dizziness.  These symptoms have now persisted for one month without significant improvement.  He had similar symptoms after Pfizer COVID vaccine #2 which persisted for about 4 weeks prior to starting to improve but which lasted for about 3 months total. He brought this to my attention at office visit on 10/27 as his symptoms had not begun to improve.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, Neuralgia
Clinical narrative: The day after vaccination the patient had onset of dense fatigue.  This symptom has been accompanied by headaches, hoarseness, increased neuropathic pain, orthostatic dizziness.  These symptoms have now persisted for one month without significant improvement.  He had similar symptoms after Pfizer COVID vaccine #2 which persisted for about 4 weeks prior to starting to improve but which lasted for about 3 months total. He brought this to my attention at office visit on 10/27 as his symptoms had not begun to improve.